Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner was added announcing changes to NIH terminology and linking to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T13:25:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:43:43.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:20:29.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the usual study content and navigation. This indicates restricted access to the study record and a disrupted user experience on this page.
    Difference
    20%
    Check dated 2026-09-21T22:13:14.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor publication update rather than a change to the trial details.
    Difference
    0.1%
    Check dated 2026-08-31T17:58:37.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a maintenance release with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-10T12:18:15.000Z thumbnail image

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.